American Psychiatric Association. Task DSM-5Force. Diagnostic and statistical manual of mental disorders: DSM‐5™. 5th ed. American Psychiatric Publishing, Inc.; 2013.

WHO. Depressive disorder (depression). 2023. https://www.who.int/news-room/fact-sheets/detail/depression. Accessed 5 Sep 2024.

WHO. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. 2022. https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide. Accessed 5 Sep 2024.

Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965. https://doi.org/10.1176/ajp.122.5.509

Article  PubMed  Google Scholar 

Xie Y, Mustafa A, Yerzhan A, Merzhakupova D, Yerlan P, Orakov N. Nuclear matrix metalloproteinases: functions resemble the evolution from the intracellular to the extracellular compartment. Cell Death Discov. 2017. https://doi.org/10.1038/cddiscovery.2017.36

Article  PubMed  PubMed Central  Google Scholar 

Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020. https://doi.org/10.3390/cells9051076

Article  PubMed  PubMed Central  Google Scholar 

Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J Neurochem. 2016. https://doi.org/10.1111/jnc.13415

Article  PubMed  Google Scholar 

Michaluk P, Mikasova L, Groc L, Frischknecht R, Choquet D, Kaczmarek L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. J Neurosci. 2009. https://doi.org/10.1523/JNEUROSCI.5346-08.2009

Article  PubMed  PubMed Central  Google Scholar 

Kaczmarek L. MMP-9 in control of synaptic plasticity: a subjective account. Opera Med Physiol. 2016. https://doi.org/10.20388/OMP2016.002.0027.

Article  Google Scholar 

Michaluk P, Kaczmarek L. Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ. 2007. https://doi.org/10.1038/sj.cdd.4402141

Article  PubMed  Google Scholar 

Milward E, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, et al. Cleavage of Myelin associated glycoprotein by matrix metalloproteinases. J Neuroimmunol. 2008. https://doi.org/10.1016/j.jneuroim.2007.11.001

Article  PubMed  Google Scholar 

Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE. 2010. https://doi.org/10.1371/journal.pone.0009166

Article  PubMed  PubMed Central  Google Scholar 

Bobińska K, Szemraj J, Czarny P, Gałecki P. Expression and activity of metalloproteinases in depression. Med Sci Monit. 2016. https://doi.org/10.12659/msm.895978

Article  PubMed  PubMed Central  Google Scholar 

Bobińska K, Szemraj J, Czarny P, Gałecki P. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder. J Affect Disord. 2016. https://doi.org/10.1016/j.jad.2016.03.068

Article  PubMed  Google Scholar 

Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor ProBDNF, in patients with major depressive disorder. PLoS ONE. 2012. https://doi.org/10.1371/journal.pone.0042676

Article  PubMed  PubMed Central  Google Scholar 

Shibasaki C, Takebayashi M, Itagaki K, Abe H, Kajitani N, Okada-Tsuchioka M, et al. Altered serum levels of matrix Metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders. Int J Neuropsychopharmacol. 2016. https://doi.org/10.1093/ijnp/pyw019

Article  PubMed  PubMed Central  Google Scholar 

Che B, Zhong C, Ge J, Li R, Zhu Z, Bu X, et al. Serum matrix Metalloproteinase-9 is associated with depression after acute ischemic stroke. Circ J. 2019. https://doi.org/10.1253/circj.CJ-19-0376

Article  PubMed  Google Scholar 

Talarowska ME, Kowalczyk M, Maes M, Carvalho A, Su KP, Szemraj J, et al. Immune to happiness - inflammatory process indicators and depressive personality traits. Arch Med Sci. 2019. https://doi.org/10.5114/aoms.2019.83146

Article  PubMed  PubMed Central  Google Scholar 

Shibasaki C, Itagaki K, Abe H, Kajitani N, Okada-Tsuchioka M, Takebayashi M. Possible association between serum matrix Metalloproteinase-9 (MMP-9) levels and relapse in depressed patients following electroconvulsive therapy (ECT). Int J Neuropsychopharmacol. 2018. https://doi.org/10.1093/ijnp/pyx086

Article  PubMed  Google Scholar 

Bijata M, Bączyńska E, Müller FE, Bijata K, Masternak J, Krzystyniak A, et al. Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behavior. Cell Rep. 2022. https://doi.org/10.1016/j.celrep.2022.110532

Article  PubMed  Google Scholar 

Alaiyed S, McCann M, Mahajan G, Rajkowska G, Stockmeier CA, Kellar KJ, et al. Venlafaxine stimulates an MMP-9-Dependent increase in excitatory/inhibitory balance in a stress model of depression. J Neurosci. 2020. https://doi.org/10.1523/JNEUROSCI.2387-19.2020

Article  PubMed  PubMed Central  Google Scholar 

Saravanan K, Keshri N, Nandeesha H, Menon V, Goud AC. Matrixmetalloproteinase-9 gene polymorphism (rs 17576) increases the risk of depressive symptoms in bipolar disorder. J Neurosci Rural Pract. 2022. https://doi.org/10.25259/JNRP-2022-6-34

Article  PubMed  PubMed Central  Google Scholar 

McGregor NW, Dimatelis JJ, Van Zyl PJ, Hemmings SMJ, Kinnear C, Russell VA, et al. A translational approach to the genetics of anxiety disorders. Behav Brain Res. 2018. https://doi.org/10.1016/j.bbr.2017.12.030

Article  PubMed  Google Scholar 

Jönsson S, Lundberg AK, Jonasson L. Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction–is it associated with depressive symptomatology? PLoS ONE. 2014. https://doi.org/10.1371/journal.pone.0105572

Article  PubMed  PubMed Central  Google Scholar 

Breviario S, Senserrich J, Florensa-Zanuy E, Garro-Martínez E, Díaz Á, Castro E, et al. Brain matrix metalloproteinase-9 activity is altered in the corticosterone mouse model of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2023. https://doi.org/10.1016/j.pnpbp.2022.110624

Article  PubMed  Google Scholar 

van der Kooij MA, Fantin M, Rejmak E, Grosse J, Zanoletti O, Fournier C, et al. Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations. Nat Commun. 2014. https://doi.org/10.1038/ncomms5995

Article  PubMed  Google Scholar 

Shishkina GT, Bannova AV, Komysheva NP, Dygalo NN. Anxiogenic-like effect of chronic lipopolysaccharide is associated with increased expression of matrix metalloproteinase 9 in the rat amygdala. Stress. 2020. https://doi.org/10.1080/10253890.2020.1793943

Article  PubMed  Google Scholar 

Tartt AN, Mariani MB, Hen R, Mann JJ, Boldrini M. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol Psychiatry. 2022. https://doi.org/10.1038/s41380-022-01520-y

Article  PubMed  PubMed Central  Google Scholar 

McEwen BS, Nasca C, Gray JD. Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016. https://doi.org/10.1038/npp.2015.171

Article  PubMed  Google Scholar 

Ghasemi M, Navidhamidi M, Rezaei F, Azizikia A, Mehranfard N. Anxiety and hippocampal neuronal activity: relationship and potential mechanisms. Cogn Affect Behav Neurosci. 2022. https://doi.org/10.3758/s13415-021-00973-y

Article  PubMed  Google Scholar 

Fujii R, Watanabe K, Okamoto N, Natsuyama T, Tesen H, Igata R, Konishi Y, Ikenouchi A, Kakeda S, Yoshimura R. Hippocampal volume and plasma Brain-Derived neurotrophic factor levels in patients with depression and healthy controls. Front Mol Neurosci. 2022. https://doi.org/10.3389/fnmol.2022.857293

Article  PubMed  PubMed Central  Google Scholar 

Liu B, Du Y, Xu C, Liu Q, Zhang L. Antidepressant effects of repeated s-ketamine administration as NMDAR antagonist: involvement of CaMKIIα and mTOR signaling in the hippocampus of CUMS mice. Brain Res. 2023. https://doi.org/10.1016/j.brainres.2023.148375

Article  PubMed